WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattDirector2024-05-223,600$129.49
$466.16kBuy
Martine A. RothblattDirector2024-05-22510$276.17
$140.85kSell
Martine A. RothblattDirector2024-05-221,290$277.13
$357.49kSell
Martine A. RothblattDirector2024-05-221,588$277.85
$441.23kSell
Martine A. RothblattDirector2024-05-22212$275.23
$58.35kSell
Martine A. RothblattDirector2024-05-213,600$129.49
$466.16kBuy
Martine A. RothblattDirector2024-05-21902$274.70
$247.78kSell
Martine A. RothblattDirector2024-05-21565$277.68
$156.89kSell
Martine A. RothblattDirector2024-05-211$278.29
$278.29Sell
Martine A. RothblattDirector2024-05-20138$274.93
$37.94kSell

1 of 55

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.55%5,567,530$1.52BInstitution
Lilly Co Eli11.84%5,251,394$1.43BInsider
Vanguard Group Inc10.56%4,683,095$1.28BInstitution
Wellington Management Group LLP7.69%3,412,260$931.14MInstitution
Avoro Capital Advisors LLC6.45%2,858,888$780.13MInstitution
Renaissance Technologies LLC4.85%2,151,714$587.16MInstitution
State Street Corp4.36%1,935,119$528.06MInstitution
Fmr LLC2.29%1,017,611$277.69MInstitution
Martine A. Rothblatt1.97%872,706$238.14MInsider
Aqr Capital Management LLC1.91%846,955$231.12MInstitution

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR87.62%12.38%Net SellingNet Selling
SRPT73.96%26.04%Net BuyingNet Selling
TECH97.68%2.32%Net BuyingNet Selling
INCY79.12%20.88%Net SellingNet Buying
BMRN96.07%1.65%Net SellingNet Selling

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 100.48% institutional shareholders, 14.19% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.84% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $1.43B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.